Preventing graft restenosis after coronary artery bypass grafting with tissue-type plasminogen activator

OBJECTIVE: To explore the feasibility and safety of using tissue-type plasminogen activator (t-PA) to prevent graft restenosis after coronary artery bypass grafting (CABG). METHODS: In this prospective observational study, 37 patients underwent CABG between June 2009 and May 2013. These patients wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ruixiong, Lan, Bin, Zhu, Tianxiang, Yang, Yanlong, Cai, Muyan, Fang, Zhongmin, Ma, Chensheng, Chen, Shu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Reaearch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469182/
https://www.ncbi.nlm.nih.gov/pubmed/28606123
http://dx.doi.org/10.1186/s40001-017-0259-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469182/
https://www.ncbi.nlm.nih.gov/pubmed/28606123
http://dx.doi.org/10.1186/s40001-017-0259-8

Ejemplares similares